Qingjuan Wu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Immune-inflammatory biomarkers and immune features in metabolic dysfunction-associated steatotic liver disease: a bibliometric study.
Journal: Frontiers in immunology
Published: June 03, 2026
The Role of Hepatic SIRT1: From Metabolic Regulation to Immune Modulation and Multi-target Therapeutic Strategies.
Journal: Journal of clinical and translational hepatology
Published: May 31, 2025
Neutrophil extracellular trapping network-associated biomarkers in liver fibrosis: machine learning and experimental validation.
Journal: Journal of translational medicine
Published: April 15, 2025
Natural bioactive compounds reprogram bile acid metabolism in MAFLD: Multi-target mechanisms and therapeutic implications.
Journal: International immunopharmacology
Published: March 05, 2025
Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021.
Journal: Scientific reports
Published: January 07, 2025
Ursolic and oleanolic acids suppress MNNG induced malignant transformation of human gastric mucosal epithelium by regulating the PI3 K/AKT pathway.
Journal: Scientific reports
Published: October 23, 2024
Extracellular Matrix Stiffness-Induced Mechanotransduction of Capillarized Liver Sinusoidal Endothelial Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 11, 2024
Mendelian randomization of chronic hepatitis B and cardiovascular disease.
Journal: Frontiers in cardiovascular medicine
Published: November 03, 2023
NLRP3 Inflammasomes: Dual Function in Infectious Diseases.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 01, 2023
NLRP3 Inflammasome Activation: A Therapeutic Target for Cerebral Ischemia-Reperfusion Injury.
Journal: Frontiers in molecular neuroscience
Published: January 02, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026